Patents by Inventor Janice M. Pfeffer

Janice M. Pfeffer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5977160
    Abstract: The invention involves a method for treating a human survivor of a heart attack and provides further improvement in survival following the heart attack by the early initiation and long-term administration of an angiotensin converting enzyme inhibitor. The angiotensin converting enzyme inhibitor may be used on its own, or in conjunction with other therapeutic compounds such as data blockers and thrombolytic agents. The preferred angiotensin converting enzyme inhibitor is captopril.
    Type: Grant
    Filed: April 10, 1992
    Date of Patent: November 2, 1999
    Assignee: Brigham and Women's Hospital, Inc.
    Inventors: Marc A. Pfeffer, Janice M. Pfeffer, Eugene Braunwald
  • Patent number: 5972990
    Abstract: The invention involves a method for treating a human survivor of a heart attack and provides further improvement in survival following the heart attack by the early initiation and long-term administration of a renin-angiotensin system inhibitor, preferably an angiotensin converting enzyme inhibitor. The inhibitor may be used on its own, or in conjunction with other therapeutic compounds such as data blockers and thrombolytic agents. The preferred inhibitor is captopril.
    Type: Grant
    Filed: November 25, 1992
    Date of Patent: October 26, 1999
    Assignee: Brigham and Women's Hospital, Inc.
    Inventors: Marc A. Pfeffer, Janice M. Pfeffer, Eugene Braunwald
  • Patent number: 5952305
    Abstract: The invention involves a method for treating a human survivor of a heart attack and provides further improvement in survival following the heart attack by the early initiation and long-term administration of a renin-angiotensin system inhibitor, preferably an angiotensin converting enzyme inhibitor. The inhibitor may be used on its own, or in conjunction with other therapeutic compounds such as data blockers and thrombolytic agents. The preferred inhibitor is captopril.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 14, 1999
    Assignee: Brigham and Women's Hospital, Inc.
    Inventors: Marc A. Pfeffer, Janice M. Pfeffer, Eugene Braunwald